This work on APBD is our third study using a LC–MS/MS proteomic analysis of lymphoblasts of a rare genetic CNS disorder; it was preceded by analyses of lymphoblast proteomes of persons with neurologic diseases due to mutations of ARID1B and HERC2 (44, 45). This evidence concerns the gene HERC2 and central nervous system disorder.